What is the official ID of this bill?
The official print number for this legislation is HR 661.
US-Israel Medical Collaboration: New Drugs, Technologies, and Healthcare
This act aims to strengthen cooperation between the United States and Israel in the medical field. This means faster development of new drugs, medical technologies, and better healthcare management, which could lead to access to more modern therapies and services for citizens. The collaboration also includes the exchange of knowledge and experience, potentially improving the quality of healthcare.
Key points
Joint research on new drugs and medical technologies, including devices and digital health solutions.
Supporting innovation and startups in the health sector, which can accelerate the market introduction of new solutions.
Facilitating medical data exchange for research purposes and strengthening patient privacy protection.
Collaboration in telemedicine and digital health solutions, potentially improving access to medical care.
Joint efforts in combating infectious diseases, including vaccine development and epidemiological data exchange.
Development of biological product manufacturing, which could provide access to more affordable and available life-saving treatments.
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.